0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      PyAMPA: a high-throughput prediction and optimization tool for antimicrobial peptides

      research-article
      1 , 1 , 2 , 2 , , 1 ,
      mSystems
      American Society for Microbiology
      antimicrobial peptide

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          The alarming rise of antibiotic-resistant bacterial infections is driving efforts to develop alternatives to conventional antibiotics. In this context, antimicrobial peptides (AMPs) have emerged as promising candidates for their ability to target a broad range of microorganisms. However, the development of AMPs with optimal potency, selectivity, and/or stability profiles remains a challenge. To address it, computational tools for predicting AMP properties and designing novel peptides have gained increasing attention. PyAMPA is a novel platform for AMP discovery. It consists of five modules, namely AMPScreen, AMPValidate, AMPSolve, AMPMutate, and AMPOptimize, that allow high-throughput proteome inspection, candidate screening, and optimization through point-mutation and genetic algorithms. The platform also offers additional tools for predicting and evaluating AMP properties, including antimicrobial and cytotoxic activity, and peptide half-life. By providing innovative and accessible inroads into AMP motifs in proteomes, PyAMPA will enable advances in AMP development and potential translation into clinically useful molecules. PyAMPA is available at: https://github.com/SysBioUAB/PyAMPA

          IMPORTANCE

          This paper introduces PyAMPA, a new bioinformatics platform designed for the discovery and optimization of antimicrobial peptides (AMPs). It addresses the urgent need for new antimicrobials due to the rise of antibiotic-resistant infections. PyAMPA, with its five predictive modules -AMPScreen, AMPValidate, AMPSolve, AMPMutate and AMPOptimize, enables high-throughput screening of proteomes to identify potential AMP motifs and optimize them for clinical use. Its unique approach, combining prediction, design, and optimization tools, makes PyAMPA a robust solution for developing new AMP-based therapies, offering a significant advance in combatting antibiotic resistance.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Global trends in emerging infectious diseases

          The next new disease Emerging infectious diseases are a major threat to health: AIDS, SARS, drug-resistant bacteria and Ebola virus are among the more recent examples. By identifying emerging disease 'hotspots', the thinking goes, it should be possible to spot health risks at an early stage and prepare containment strategies. An analysis of over 300 examples of disease emerging between 1940 and 2004 suggests that these hotspots can be accurately mapped based on socio-economic, environmental and ecological factors. The data show that the surveillance effort, and much current research spending, is concentrated in developed economies, yet the risk maps point to developing countries as the more likely source of new diseases. Supplementary information The online version of this article (doi:10.1038/nature06536) contains supplementary material, which is available to authorized users.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.

            The aim of broth and agar dilution methods is to determine the lowest concentration of the assayed antimicrobial agent (minimal inhibitory concentration, MIC) that, under defined test conditions, inhibits the visible growth of the bacterium being investigated. MIC values are used to determine susceptibilities of bacteria to drugs and also to evaluate the activity of new antimicrobial agents. Agar dilution involves the incorporation of different concentrations of the antimicrobial substance into a nutrient agar medium followed by the application of a standardized number of cells to the surface of the agar plate. For broth dilution, often determined in 96-well microtiter plate format, bacteria are inoculated into a liquid growth medium in the presence of different concentrations of an antimicrobial agent. Growth is assessed after incubation for a defined period of time (16-20 h) and the MIC value is read. This protocol applies only to aerobic bacteria and can be completed in 3 d.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              In Silico Approach for Predicting Toxicity of Peptides and Proteins

              Background Over the past few decades, scientific research has been focused on developing peptide/protein-based therapies to treat various diseases. With the several advantages over small molecules, including high specificity, high penetration, ease of manufacturing, peptides have emerged as promising therapeutic molecules against many diseases. However, one of the bottlenecks in peptide/protein-based therapy is their toxicity. Therefore, in the present study, we developed in silico models for predicting toxicity of peptides and proteins. Description We obtained toxic peptides having 35 or fewer residues from various databases for developing prediction models. Non-toxic or random peptides were obtained from SwissProt and TrEMBL. It was observed that certain residues like Cys, His, Asn, and Pro are abundant as well as preferred at various positions in toxic peptides. We developed models based on machine learning technique and quantitative matrix using various properties of peptides for predicting toxicity of peptides. The performance of dipeptide-based model in terms of accuracy was 94.50% with MCC 0.88. In addition, various motifs were extracted from the toxic peptides and this information was combined with dipeptide-based model for developing a hybrid model. In order to evaluate the over-optimization of the best model based on dipeptide composition, we evaluated its performance on independent datasets and achieved accuracy around 90%. Based on above study, a web server, ToxinPred has been developed, which would be helpful in predicting (i) toxicity or non-toxicity of peptides, (ii) minimum mutations in peptides for increasing or decreasing their toxicity, and (iii) toxic regions in proteins. Conclusion ToxinPred is a unique in silico method of its kind, which will be useful in predicting toxicity of peptides/proteins. In addition, it will be useful in designing least toxic peptides and discovering toxic regions in proteins. We hope that the development of ToxinPred will provide momentum to peptide/protein-based drug discovery (http://crdd.osdd.net/raghava/toxinpred/).
                Bookmark

                Author and article information

                Contributors
                Role: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Software
                Role: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Writing – review and editing
                Role: InvestigationRole: Methodology
                Role: ConceptualizationRole: Funding acquisitionRole: Project administrationRole: ResourcesRole: SupervisionRole: Writing – original draftRole: Writing – review and editing
                Role: ConceptualizationRole: Funding acquisitionRole: Project administrationRole: ResourcesRole: SupervisionRole: Writing – original draftRole: Writing – review and editing
                Role: Editor
                Journal
                mSystems
                mSystems
                msystems
                mSystems
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                2379-5077
                July 2024
                27 June 2024
                27 June 2024
                : 9
                : 7
                : e01358-23
                Affiliations
                [1 ]Systems Biology of Infection Lab, Department of Biochemistry and Molecular Biology, Biosciences Faculty, Universitat Autònoma de Barcelona; , Barcelona, Spain
                [2 ]Barcelona Biomedical Research Park, Department of Medicine and Life Sciences, Universitat Pompeu Fabra; , Barcelona, Spain
                London School of Hygiene & Tropical Medicine; , London, United Kingdom
                Author notes
                Address correspondence to David Andreu, david.andreu@ 123456upf.edu
                Address correspondence to Marc Torrent, marc.torrent@ 123456uab.cat

                Present address: Instituto de Acuicultura Torre de la Sal, Consejo Superior de Investigaciones Científicas (IATS-CSIC), Ribera de Cabanes, Castellón, Spain

                The authors declare no conflict of interest.

                Author information
                https://orcid.org/0000-0002-5194-1279
                https://orcid.org/0009-0003-8474-3951
                https://orcid.org/0000-0002-6317-6666
                https://orcid.org/0000-0001-6567-3474
                Article
                01358-23 msystems.01358-23
                10.1128/msystems.01358-23
                11264690
                38934543
                3dfd339a-c4a5-4441-8d13-e473450a15a0
                Copyright © 2024 Ramos-Llorens et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 23 December 2023
                : 27 May 2024
                Page count
                supplementary-material: 1, authors: 5, Figures: 4, Tables: 3, Equations: 5, References: 43, Pages: 15, Words: 6765
                Funding
                Funded by: Ministerio de Ciencia e Innovación (MCIN), FundRef https://doi.org/10.13039/501100004837;
                Award ID: PID2020-114627RB-I00/AEI/10.13039/501100011033
                Award Recipient :
                Funded by: Ministerio de Ciencia e Innovación (MCIN), FundRef https://doi.org/10.13039/501100004837;
                Award ID: PDC2021-121544-I00/AEI/10.13039/501100011033
                Award Recipient :
                Funded by: European Society of Clinical Microbiology and Infectious Diseases (ESCMID);
                Award ID: ESCMID2022
                Award Recipient :
                Funded by: Ministerio de Ciencia e Innovación (MCIN), FundRef https://doi.org/10.13039/501100004837;
                Award ID: PID2020-113184RB-C22/AEI/10.13039/501100011033
                Award Recipient :
                Funded by: La Caixa Health Foundation;
                Award ID: HR17-00409
                Award Recipient :
                Categories
                Methods and Protocols
                antimicrobial-chemotherapy, Antimicrobial Chemotherapy
                Custom metadata
                July 2024

                antimicrobial peptide
                antimicrobial peptide

                Comments

                Comment on this article